Column

While there are, in theory, several options for countering an infectious agent like the coronavirus, the rapid development of an antiviral drug remains a daunting challenge. Let’s take a look at the approaches envisioned by modern biochemistry to combat the current epidemic of COVID-19 caused by this type of virus. Download the column